These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32394283)

  • 21. [Ketogenic diet may control seizures by increasing the binding potential of the benzodiazepine receptor: a speculation from the [11C] flumazenil-PET study].
    Kumada T; Nishii R; Higashi T; Miyajima T; Oda N; Shimomura H; Saito K; Fujii T
    No To Hattatsu; 2012 Jan; 44(1):50-4. PubMed ID: 22352031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke.
    Heiss WD; Sobesky J; Smekal Uv; Kracht LW; Lehnhardt FG; Thiel A; Jacobs AH; Lackner K
    Stroke; 2004 Aug; 35(8):1892-8. PubMed ID: 15218157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [11C]Flumazenil PET in patients with epilepsy with dual pathology.
    Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT
    Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
    Koepp MJ; Labbé C; Richardson MP; Brooks DJ; Van Paesschen W; Cunningham VJ; Duncan JS
    Brain; 1997 Oct; 120 ( Pt 10)():1865-76. PubMed ID: 9365376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.
    Kaunzner UW; Kang Y; Monohan E; Kothari PJ; Nealon N; Perumal J; Vartanian T; Kuceyeski A; Vallabhajosula S; Mozley PD; Riley CS; Newman SM; Gauthier SA
    Mult Scler Relat Disord; 2017 Jul; 15():27-33. PubMed ID: 28641769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of neuroinflammation to changes in [
    Parente A; Vállez García D; Shoji A; Lopes Alves I; Maas B; Zijlma R; Dierckx RA; Buchpiguel CA; de Vries EF; Doorduin J
    Nucl Med Biol; 2017 Jun; 49():50-56. PubMed ID: 28364664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis.
    Koepp MJ; Hand KS; Labbé C; Richardson MP; Van Paesschen W; Baird VH; Cunningham VJ; Bowery NG; Brooks DJ; Duncan JS
    Ann Neurol; 1998 May; 43(5):618-26. PubMed ID: 9585356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex.
    Nagy F; Chugani DC; Juhász C; da Silva EA; Muzik O; Kupsky W; Canady A; Watson C; Shah J; Chugani HT
    J Cereb Blood Flow Metab; 1999 Sep; 19(9):939-47. PubMed ID: 10478645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
    Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
    Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients.
    Hammers A; Koepp MJ; Richardson MP; Hurlemann R; Brooks DJ; Duncan JS
    Brain; 2003 Jun; 126(Pt 6):1300-18. PubMed ID: 12764053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal decreases of cortical GABAA receptor binding remote from the primary seizure focus: what do they indicate?
    Juhász C; Asano E; Shah A; Chugani DC; Batista CE; Muzik O; Sood S; Chugani HT
    Epilepsia; 2009 Feb; 50(2):240-50. PubMed ID: 18637829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
    Bodini B; Poirion E; Tonietto M; Benoit C; Palladino R; Maillart E; Portera E; Battaglini M; Bera G; Kuhnast B; Louapre C; Bottlaender M; Stankoff B
    J Nucl Med; 2020 Jul; 61(7):1043-1049. PubMed ID: 32005777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
    Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
    Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of reference tissue modelling for [11C]flumazenil positron emission tomography following head injury.
    Geeraerts T; Coles JP; Aigbirhio FI; Pickard JD; Menon DK; Fryer TD; Hong YT
    Ann Nucl Med; 2011 Jul; 25(6):396-405. PubMed ID: 21461598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies.
    Klumpers UM; Veltman DJ; Boellaard R; Comans EF; Zuketto C; Yaqub M; Mourik JE; Lubberink M; Hoogendijk WJ; Lammertsma AA
    J Cereb Blood Flow Metab; 2008 Mar; 28(3):579-87. PubMed ID: 17928801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy.
    Juhász C; Muzik O; Chugani DC; Shen C; Janisse J; Chugani HT
    Epilepsia; 2001 Oct; 42(10):1320-6. PubMed ID: 11737167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by
    Barletta VT; Herranz E; Treaba CA; Ouellette R; Mehndiratta A; Loggia ML; Klawiter EC; Ionete C; Jacob SA; Mainero C
    Mult Scler; 2020 May; 26(6):668-678. PubMed ID: 30973800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.
    Giannetti P; Politis M; Su P; Turkheimer F; Malik O; Keihaninejad S; Wu K; Reynolds R; Nicholas R; Piccini P
    Neurobiol Dis; 2014 May; 65():203-10. PubMed ID: 24508617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Recovery After Ischemic Stroke Is Associated With Reduced GABAergic Inhibition in the Cerebral Cortex: A GABA PET Study.
    Kim YK; Yang EJ; Cho K; Lim JY; Paik NJ
    Neurorehabil Neural Repair; 2014 Jul; 28(6):576-83. PubMed ID: 24463186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation.
    Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B
    Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.